Delivery Order SPE2DB24D2205-SPE2DB25FEGBE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. This competitively awarded, non-set-aside contract carries a ceiling value of $4,470.50 and is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains operations as...
- The Defense Logistics Agency awarded a $75,338.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringe format, with an ultimate completion date of August 18, 2025. This non-set-aside, competitively awarded contract represents a single delivery order fulfillment under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The vaccine will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,064.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5ML) on August 11, 2025, with completion targeted for August 12, 2025. This non-set-aside delivery order represents a small-value transaction under AmerisourceBergen's broader pharmaceutical supply arrangement with DLA. The product will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in syringe form (0.5mL) with a ceiling value of $1,064.40. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract utilizes no set-aside designation and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Boostrix TDAP vaccine in 0.5ML syringes, with a ceiling value of $7,592.10. This is a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $39,915.00 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Boostrix TDAP vaccine syringes (0.5mL). This firm fixed price delivery order, with an ultimate completion date of July 21, 2025, represents performance at the contractor's Conshohocken, Pennsylvania facility. The award was not designated as a set-aside contract and was competitively awarded to the prime contractor. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,594.20 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ML syringes. This non-competitive delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a small-value transaction under a firm fixed-price arrangement. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) on August 11, 2025, with a ceiling value of $22,083.83. This firm fixed-price contract, with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with the DLA. The contract is unclassified as a set-aside and will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a $4,733.48 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This non-set-aside contract, which carries an ultimate completion date of August 14, 2025, operates under a firm fixed price structure. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this order. The contract represents a small-value transaction typical of routine...
- The Defense Logistics Agency awarded a delivery order valued at approximately $31K to AmerisourceBergen Drug Corp for supply of Boostrix TDAP vaccine in 0.5mL syringe format, with an ultimate completion date of August 13, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The contract was awarded on August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGBEDelivery Order
The Defense Logistics Agency awarded a $13,446.66 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including vaccines, medications, medical devices, and specialized healthcare commodities. The delivery order demonstrates AmerisourceBergen's role as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and other government healthcare systems through the DLA's flexible contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 8/11/25 |